137 related articles for article (PubMed ID: 32185997)
1. Evaluation of efficacy and safety of gandouling plus sodium dimercaptosulphonate in treatment of patients with neurological Wilson's disease from China.
Zhang J; Xie D; Li Y; Li L; Han H; Zhang J; Chen H; Wang M; Guo Y
J Tradit Chin Med; 2018 Oct; 38(5):781-786. PubMed ID: 32185997
[TBL] [Abstract][Full Text] [Related]
2. Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease.
Zhang J; Xiao L; Yang W
BMC Neurol; 2020 Jun; 20(1):255. PubMed ID: 32593295
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and safety of Gandouling plus low-dose D-penicillamine for treatment of Wilson's disease with neurological symptoms.
Zhang J; Li L; Chen H; Yang W
J Tradit Chin Med; 2018 Feb; 38(1):89-94. PubMed ID: 32185956
[TBL] [Abstract][Full Text] [Related]
4. Haemolysis during sodium dimercaptosulphonate therapy for Wilson's disease in G6PD-deficient patients: First report of two cases.
Lai S; Huang YQ; Liu AQ; Wu HW
J Clin Pharm Ther; 2017 Dec; 42(6):783-785. PubMed ID: 28635014
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease.
Xu SQ; Li XF; Zhu HY; Liu Y; Fang F; Chen L
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):743-747. PubMed ID: 24142730
[TBL] [Abstract][Full Text] [Related]
6. Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease.
Wang XP; Yang RM; Ren MS; Sun BM
Funct Neurol; 2003; 18(3):149-53. PubMed ID: 14703896
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Gandou Decoction IV combined with short-term decoppering therapy with sodium dimercapto-sulphonate on serum indexes of hepatic fibrosis in patients with Wilson' s disease].
Xue BC; Yang RM; Hu JY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Sep; 27(9):785-8. PubMed ID: 17969887
[TBL] [Abstract][Full Text] [Related]
8. [Study on improvement of liver cirrhosis and liver function in hepatolenticular degeneration patients treated with integrated Traditional and Western medicine].
Hong M; Wang G; Yang R
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Dec; 20(12):890-2. PubMed ID: 11938856
[TBL] [Abstract][Full Text] [Related]
9. Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China.
Li LY; Yang WM; Chen HZ; Wu YH; Fang X; Zhang J; Wang Z; Han YS; Wang Y
PLoS One; 2015; 10(4):e0124569. PubMed ID: 25910248
[TBL] [Abstract][Full Text] [Related]
10. Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson's disease patients with penicillamine-induced allergy or early neurological deterioration.
Zhu XQ; Li LY; Yang WM; Wang Y
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32809015
[TBL] [Abstract][Full Text] [Related]
11. Early neurological worsening in patients with Wilson's disease.
Litwin T; Dzieżyc K; Karliński M; Chabik G; Czepiel W; Członkowska A
J Neurol Sci; 2015 Aug; 355(1-2):162-7. PubMed ID: 26071888
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of combined sodium dimercaptopropanesulfonate and zinc treatment in neurological Wilson's disease with D-penicillamine treatment failure.
Chen D; Zhou X; Hou H; Feng L; Liu J; Liang Y; Lin X; Zhang J; Wu C; Liang X; Pei Z; Li X
Ther Adv Neurol Disord; 2016 Jul; 9(4):310-6. PubMed ID: 27366238
[TBL] [Abstract][Full Text] [Related]
13. Successful Treatment of Hypersplenism in Wilson's Disease by Partial Splenic Embolization.
Li LY; Chen HZ; Bao YC; Yu QS; Yang WM
J Invest Surg; 2018 Apr; 31(2):75-81. PubMed ID: 28135891
[TBL] [Abstract][Full Text] [Related]
14. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
[TBL] [Abstract][Full Text] [Related]
15. Comparative assessment of clinical rating scales in Wilson's disease.
Volpert HM; Pfeiffenberger J; Gröner JB; Stremmel W; Gotthardt DN; Schäfer M; Weiss KH; Weiler M
BMC Neurol; 2017 Jul; 17(1):140. PubMed ID: 28732478
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and safety of Chinese herbal medicine for Wilson's disease: a systematic review of 9 randomized controlled trials.
Wang Y; Xie CL; Fu DL; Lu L; Lin Y; Dong QQ; Wang XT; Zheng GQ
Complement Ther Med; 2012 Jun; 20(3):143-54. PubMed ID: 22500664
[TBL] [Abstract][Full Text] [Related]
17. [Values of serum copper and serum free copper in the diagnosis and monitoring of Wilson's disease and its carriers].
Zhou XX; Li XH; Huang HW; Liu B; Zhu RL; Liang YY; Zhu JZ; Liang XL
Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(39):2757-60. PubMed ID: 22322054
[TBL] [Abstract][Full Text] [Related]
18. A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator.
Zhou X; Xiao X; Li XH; Qin HL; Pu XY; Chen DB; Wu C; Feng L; Liang XL
J Neurol; 2020 Jun; 267(6):1643-1650. PubMed ID: 32060651
[TBL] [Abstract][Full Text] [Related]
19. [Mild cognitive impairment and depressive symptoms in patients with Wilson's disease under long-term therapy].
Günther P; Hermann W
Fortschr Neurol Psychiatr; 2012 Mar; 80(3):149-53. PubMed ID: 22407412
[TBL] [Abstract][Full Text] [Related]
20. Gandouling inhibits hepatic fibrosis in Wilson's disease through Wnt-1/β-catenin signaling pathway.
Cheng C; Wang Q; Huang Y; Xue Q; Wang Y; Wu P; Liao F; Miao C
J Ethnopharmacol; 2023 Jul; 311():116445. PubMed ID: 37015279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
